Nigeria introduced the human papillomavirus (HPV) vaccine into its national immunization program in October 2023 to reduce the risk of HPV-associated cancers. The program targets girls aged 9 to 14, with initial uptake reaching 80 percent in targeted areas during the campaign weeks. However, gaps remain in reaching girls who are out of school or living in hard-to-reach areas. Learn more about the key takeaways from multistakeholder consultation workshops.